P&G Health Q1 FY27 Sales Up 7% to ₹356 Cr, PAT Up 45%

Procter & Gamble Health Ltd. announced its first quarter results for the period ended June 30, 2026. The company reported sales of ₹356 crores, marking a 7% increase year-over-year, attributed to strong brand fundamentals, effective retail execution, and positive consumer reception to new products. Profit After Tax (PAT) surged by 45% to ₹96 crores, boosted by sales growth, improved supply chain and go-to-market capabilities, and a one-time gain from the sale of an immovable asset. Excluding this one-time gain, operational PAT grew by 9% to ₹72 crores. The company highlighted its strong start to the financial year, driven by consumer response to innovations and strengthened operational capabilities.